BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Zimmer Biomet Announces Appointment of Louis A. Shapiro to Board of Directors

  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Louis A. Shapiro , formerly the President and Chief Executive Officer of the Hospital for Special Surgery (HSS), has been appointed to the Board, effective immediately.

  January 5, 2024

   · 

  4 min read
• Business

  AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance

  AngioDynamics, Inc. (NASDAQ: ANGO) today announced financial results for the second quarter of fiscal year 2024, which ended November 30, 2023.

  January 5, 2024

   · 

  26 min read
• Business

  Stryker to announce financial results for its fourth quarter and full year 2023

  Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024.

  January 5, 2024

   · 

  1 min read
• Business

  Twist Bioscience Appoints Adam Laponis as Chief Financial Officer

  Twist Bioscience Corporation today announced the appointment of Adam Laponis as chief financial officer.

  January 5, 2024

   · 

  5 min read
• Biotech Bay

  Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH

  Spruce Biosciences, Inc today reported baseline characteristics of patients enrolled in the CAHmelia-203 and CAHmelia-204 clinical studies of tildacerfont for the treatment of adult classic congenital adrenal hyperplasia (CAH).

  January 5, 2024

   · 

  9 min read
• Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape

  Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler ® Knotless Anchor System and Innovative Bridgeline™ Tape.

  January 5, 2024

   · 

  5 min read
• BioMidwest

  Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System

  Endotronix, Inc. today announced the submission of a Premarket Approval (PMA) application for its Cordella™ Pulmonary Artery (PA) Sensor System to the U.S. Food and Drug Administration (FDA).

  January 5, 2024

   · 

  2 min read
• Biotech Beach

  GordonMD® Announces Second Investment in Radiopharmaceutical Biotech Radionetics Oncology

  GordonMD ® Global Investments LP, a key investor in groundbreaking healthcare solutions, announced another strategic investment in Radionetics Oncology.

  January 5, 2024

   · 

  1 min read
• Drug Development

  Kiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical Trial

  Kiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical Trial.

  January 5, 2024

   · 

  6 min read
• Deals

  NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million

  NurExone Biologic Inc. is pleased to announce that it has closed a non-brokered private placement (the “ Private Placement ”).

  January 5, 2024

   · 

  6 min read